Clinical trial
Single Nucleotide Polymorphisms and Relapse Risk in Standard Risk ALL
NCT00897507 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single Nucleotide Polymorphisms and Relapse Risk in Standard Risk ALL
- Lead sponsor
- Children's Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 13, 2004
- Completion date
- Not reported
- Enrollment
- 520 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
childhood acute lymphoblastic leukemia in remission, recurrent childhood acute lymphoblastic leukemia